Sangamo Therapeutics
- Biotech or pharma, therapeutic R&D
SGMO is not interested in additional CRO or other service providers at this time. We will not be accepting these requests.
Sangamo has proprietary editing, capsid & integrase technologies for the treatment of rare disease & neurological disorders.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}